Actively Recruiting

Age: 18Years +
All Genders
ID07189806

A Study of Mild, Moderate and Severe Asthma Characterising Phenotypes and Endotypes and Their Long-Term Associations with Exacerbations and Disease Progression

Led by Hvivo · Updated on 2025-09-24

250

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

H

Hvivo

Lead Sponsor

K

King's College London

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying how asthma varies among adults aged 18 and older, aiming to understand different asthma types and monitor changes over time. The study focuses on causes and triggers of asthma flare-ups, symptoms, airway inflammation, and how these factors influence respiratory health. This long-term observational study will help improve knowledge of asthma progression and outcomes by gathering detailed information from patients with mild to severe asthma. Participants will attend an initial screening visit to confirm eligibility and assess their asthma. This is followed by about five annual clinic visits and periodic phone follow-ups. Between annual visits, participants will perform self-assessments at home every six months and when experiencing cold-like symptoms. At home, participants will collect nasal and throat swabs and complete symptom, medication, and lung function diaries. The study may also include optional sub-studies involving additional tests and challenges. During the clinic visits, researchers will perform assessments such as spirometry, lung function tests, blood and respiratory sample collection, allergy skin prick tests, and questionnaires about asthma control and quality of life. Participants will be monitored for any side effects from tests like the methacholine challenge. Data collected will measure asthma exacerbation frequency and severity, lung function changes, inflammation markers, and symptom control over at least five years. Participants may withdraw at any time, and abnormal findings will be shared with them and their healthcare providers.

CONDITIONS

Brief Title

Longitudinal Phenotyping and Endotyping Study in Adult Patients With Mild, Moderate, or Severe Asthma

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female patients aged 18 years or older who have signed an informed consent form
  • Patients attending hVIVO respiratory clinics with a clinical diagnosis of asthma
  • Positive response to methacholine challenge test, bronchodilator responsiveness test, or peak flow variability over 20%
  • Documented improvement in lung function after regular asthma treatment or physician diagnosis of current asthma
  • Ability to follow study requirements as judged by the investigator
Not Eligible

You will not qualify if you...

  • Asthma patients not attending hVIVO respiratory clinics
  • Primary respiratory diagnosis other than asthma (co-diagnosis allowed)
  • Females who are breastfeeding or have a positive pregnancy test during screening
  • Patients unlikely to complete 5 years of follow-up due to literacy, substance abuse, or life-threatening conditions
  • Contraindications for lung function testing such as hemoptysis, pulmonary hypertension, pneumothorax, unstable cardiovascular status, aneurysms, recent eye or thoracic surgery
  • History of anaphylaxis or severe allergic reactions in lifetime

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surveillance

Duration - At least 5 years

Participants are observed with yearly clinic visits and intermittent at-home self-monitoring to assess asthma progression, symptoms, and biomarkers.

Yearly clinic visits and home self-assessments every 6 months and during respiratory symptoms

Trial Site Locations

Total: 1 location

1

hVIVO Services Limited, 40 Bank Street

London, United Kingdom, E14 5NR

Actively Recruiting

Loading map...

Research Team

A

Alex Mann

A

Alexandre Lima, MD-PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Investigating Astaxanthin as a Novel Therapy for Asthma Mana...

Asthma (Diagnosis)

Actively Recruiting

1 location

Comparative Effects of Alternate Nostril Breathing Versus Bu...

Asthma (Diagnosis)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here